Cargando…

Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabbout, Rima, Belousova, Elena, Benedik, Mirjana P., Carter, Tom, Cottin, Vincent, Curatolo, Paolo, Dahlin, Maria, D´Amato, Lisa, d'Augères, Guillaume Beaure, de Vries, Petrus J., Ferreira, José C., Feucht, Martha, Fladrowski, Carla, Hertzberg, Christoph, Jozwiak, Sergiusz, Lawson, John A., Macaya, Alfons, Marques, Ruben, O'Callaghan, Finbar, Qin, Jiong, Sander, Valentin, Sauter, Matthias, Shah, Seema, Takahashi, Yukitoshi, Touraine, Renaud, Youroukos, Sotiris, Zonnenberg, Bernard, Jansen, Anna, Kingswood, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398114/
https://www.ncbi.nlm.nih.gov/pubmed/30868117
http://dx.doi.org/10.1002/epi4.12286
_version_ 1783399530981490688
author Nabbout, Rima
Belousova, Elena
Benedik, Mirjana P.
Carter, Tom
Cottin, Vincent
Curatolo, Paolo
Dahlin, Maria
D´Amato, Lisa
d'Augères, Guillaume Beaure
de Vries, Petrus J.
Ferreira, José C.
Feucht, Martha
Fladrowski, Carla
Hertzberg, Christoph
Jozwiak, Sergiusz
Lawson, John A.
Macaya, Alfons
Marques, Ruben
O'Callaghan, Finbar
Qin, Jiong
Sander, Valentin
Sauter, Matthias
Shah, Seema
Takahashi, Yukitoshi
Touraine, Renaud
Youroukos, Sotiris
Zonnenberg, Bernard
Jansen, Anna
Kingswood, John C.
author_facet Nabbout, Rima
Belousova, Elena
Benedik, Mirjana P.
Carter, Tom
Cottin, Vincent
Curatolo, Paolo
Dahlin, Maria
D´Amato, Lisa
d'Augères, Guillaume Beaure
de Vries, Petrus J.
Ferreira, José C.
Feucht, Martha
Fladrowski, Carla
Hertzberg, Christoph
Jozwiak, Sergiusz
Lawson, John A.
Macaya, Alfons
Marques, Ruben
O'Callaghan, Finbar
Qin, Jiong
Sander, Valentin
Sauter, Matthias
Shah, Seema
Takahashi, Yukitoshi
Touraine, Renaud
Youroukos, Sotiris
Zonnenberg, Bernard
Jansen, Anna
Kingswood, John C.
author_sort Nabbout, Rima
collection PubMed
description OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of TSC were collected from multiple countries worldwide. Epilepsy variables included seizure type, age at onset, type of treatment, and treatment outcomes and association with genotype, seizures control, and intellectual disability. As for noninterventional registries, the study protocol did not specify any particular clinical instruments, laboratory investigations, or intervention. Evaluations included those required for diagnosis and management following local best practice. RESULTS: Epilepsy was reported in 83.6% of patients (1852/2216) at baseline; 38.9% presented with infantile spasms and 67.5% with focal seizures. The mean age at diagnosis of infantile spasms was 0.4 year (median <1 year; range <1‐30 years) and at diagnosis of focal seizures was 2.7 years (median 1 year; range <1‐66 years). A total of 1469 patients (79.3%) were diagnosed with epilepsy <2 years. The rate of infantile spasms was higher in patients with a TSC 2 mutation than in patients with a TSC1 mutation (47.3% vs 23%). ɣ‐aminobutyric acid (GABA)ergic drugs were the most common treatment modality for both infantile spasms (78.7%) and focal seizures (65.5%). Infantile spasms and focal seizures were controlled in 76.3% and 58.2% of patients, respectively. Control of seizures was associated with lower rates of intellectual disability in both groups. SIGNIFICANCE: This registry reports the largest international cohort of patients with TSC. Findings confirmed the typical onset pattern of infantile spasms and other focal seizures in the first 2 years of life, and the high rates of infantile spasms in patients with TSC2 mutation. Our results underscored the occurrence of focal seizures at all ages, including an onset that preceded emergence of infantile spasms. Seizure control was shown to be associated with lower rates of intellectual disability but did not preclude the presence of intellectual disability.
format Online
Article
Text
id pubmed-6398114
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63981142019-03-13 Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study Nabbout, Rima Belousova, Elena Benedik, Mirjana P. Carter, Tom Cottin, Vincent Curatolo, Paolo Dahlin, Maria D´Amato, Lisa d'Augères, Guillaume Beaure de Vries, Petrus J. Ferreira, José C. Feucht, Martha Fladrowski, Carla Hertzberg, Christoph Jozwiak, Sergiusz Lawson, John A. Macaya, Alfons Marques, Ruben O'Callaghan, Finbar Qin, Jiong Sander, Valentin Sauter, Matthias Shah, Seema Takahashi, Yukitoshi Touraine, Renaud Youroukos, Sotiris Zonnenberg, Bernard Jansen, Anna Kingswood, John C. Epilepsia Open Full‐length Original Research OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of TSC were collected from multiple countries worldwide. Epilepsy variables included seizure type, age at onset, type of treatment, and treatment outcomes and association with genotype, seizures control, and intellectual disability. As for noninterventional registries, the study protocol did not specify any particular clinical instruments, laboratory investigations, or intervention. Evaluations included those required for diagnosis and management following local best practice. RESULTS: Epilepsy was reported in 83.6% of patients (1852/2216) at baseline; 38.9% presented with infantile spasms and 67.5% with focal seizures. The mean age at diagnosis of infantile spasms was 0.4 year (median <1 year; range <1‐30 years) and at diagnosis of focal seizures was 2.7 years (median 1 year; range <1‐66 years). A total of 1469 patients (79.3%) were diagnosed with epilepsy <2 years. The rate of infantile spasms was higher in patients with a TSC 2 mutation than in patients with a TSC1 mutation (47.3% vs 23%). ɣ‐aminobutyric acid (GABA)ergic drugs were the most common treatment modality for both infantile spasms (78.7%) and focal seizures (65.5%). Infantile spasms and focal seizures were controlled in 76.3% and 58.2% of patients, respectively. Control of seizures was associated with lower rates of intellectual disability in both groups. SIGNIFICANCE: This registry reports the largest international cohort of patients with TSC. Findings confirmed the typical onset pattern of infantile spasms and other focal seizures in the first 2 years of life, and the high rates of infantile spasms in patients with TSC2 mutation. Our results underscored the occurrence of focal seizures at all ages, including an onset that preceded emergence of infantile spasms. Seizure control was shown to be associated with lower rates of intellectual disability but did not preclude the presence of intellectual disability. John Wiley and Sons Inc. 2018-12-21 /pmc/articles/PMC6398114/ /pubmed/30868117 http://dx.doi.org/10.1002/epi4.12286 Text en © 2018 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full‐length Original Research
Nabbout, Rima
Belousova, Elena
Benedik, Mirjana P.
Carter, Tom
Cottin, Vincent
Curatolo, Paolo
Dahlin, Maria
D´Amato, Lisa
d'Augères, Guillaume Beaure
de Vries, Petrus J.
Ferreira, José C.
Feucht, Martha
Fladrowski, Carla
Hertzberg, Christoph
Jozwiak, Sergiusz
Lawson, John A.
Macaya, Alfons
Marques, Ruben
O'Callaghan, Finbar
Qin, Jiong
Sander, Valentin
Sauter, Matthias
Shah, Seema
Takahashi, Yukitoshi
Touraine, Renaud
Youroukos, Sotiris
Zonnenberg, Bernard
Jansen, Anna
Kingswood, John C.
Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title_full Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title_fullStr Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title_full_unstemmed Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title_short Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
title_sort epilepsy in tuberous sclerosis complex: findings from the tosca study
topic Full‐length Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398114/
https://www.ncbi.nlm.nih.gov/pubmed/30868117
http://dx.doi.org/10.1002/epi4.12286
work_keys_str_mv AT nabboutrima epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT belousovaelena epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT benedikmirjanap epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT cartertom epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT cottinvincent epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT curatolopaolo epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT dahlinmaria epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT damatolisa epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT daugeresguillaumebeaure epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT devriespetrusj epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT ferreirajosec epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT feuchtmartha epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT fladrowskicarla epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT hertzbergchristoph epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT jozwiaksergiusz epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT lawsonjohna epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT macayaalfons epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT marquesruben epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT ocallaghanfinbar epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT qinjiong epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT sandervalentin epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT sautermatthias epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT shahseema epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT takahashiyukitoshi epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT tourainerenaud epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT youroukossotiris epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT zonnenbergbernard epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT jansenanna epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT kingswoodjohnc epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy
AT epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy